TCM
EIDX

Tekla Capital Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Tekla Capital Management’s Portfolio EIDX Stock Details EIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
2020
Q4 		$2.63M Hold
2020
Q3 		$1.01M Hold
2020
Q2 		$953K Hold
2020
Q1 		$980K Hold
2019
Q4 		$1.15M Buy
2019
Q1 		– Sell
2018
Q4 		$384K Hold
2018
Q3 		$278K Buy